Secondary outcomes
CGIS, Self-harm, UC
SECONDARY, ADVERSE EVENT
After adjusting for HoNOSCA-SR at entry, gender, clinical diagnosis and clustering, the difference in mean HoNOSCA-SR scores between the trial arms (MT-UC) at 15 months was −1.71 (95% CI −2.88 to −0.55, Summary of other secondary outcomes 15 months after entry to the studyAs there was no adjustment for the hierarchical nature of the data or imbalances in clinical and demographic factors at baseline, the descriptive data should be interpreted cautiously.Calculated as the proportion of the UC group (Calculated as the proportion of the MT group (Completed only if the young person is still under the care of CAMHS/AMHS at 15 months.CGIS is only measured in those who are service users – hence missing reflects Not Applicable as well as true missing.Completed if the transition decision was to refer the young person to AMHS.Completed if the transition decision was to discharge the young person from mental health services.The TROM was completed at the first follow-up after the transition decision had been made, at either of the 9 and 15 months follow-up.Self-harm (suicide, suicide attempt and suicidal thoughts) was the most common serious adverse event (online Supplementary Table S9). None were assessed to be related to participation or the intervention, and there was no difference in pattern, severity or frequency of SAEs between trial arms.The intervention was relatively inexpensive to implement, with direct intervention delivery costs ranging between €17 and €65 per child and clinician training costs ranging between €22 and €176, depending on how training and delivery was conducted in each country.